This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (9)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Men's Health  • Prostate Disease  • Oncology  • Alert me on articles by topic

Richard M. Hoffman, MD, MPH

Arch Intern Med. 2003;163:663-665.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

PRIMARY CARE physicians should not be routinely screening for prostate cancer. There is no conclusive evidence that screening is effective in reducing prostate cancer morbidity and mortality, but there is considerable evidence that screening and treatment can be harmful. Primary care physicians should routinely discuss screening, but patients need to make an informed decision to be screened.

Prostate cancer is an important public health problem—a devastating disease that was expected to have killed more than 30 000 American men in 2002.¹ Unfortunately, our current prevention and treatment strategies are limited in their ability to reduce the burden of suffering from prostate cancer. The strongest risk factors are age, race, and family history, none of which can be modified. Although dietary micronutrients, antioxidant vitamins, and finasteride are being studied for the primary prevention of prostate cancer, we currently have no proven prevention strategy. Men with advanced cancers . . . [Full Text of this Article]

From the New Mexico Veterans Affairs Health Care System, Albuquerque. The author has no relevant financial interest in this article.

RELATED ARTICLES

Should Routine Screening for Prostate-Specific Antigen Be Recommended?
Siam Oottamasathien and E. David Crawford
Arch Intern Med. 2003;163(6):661-663.
EXTRACT | FULL TEXT  

Rebuttal by Drs Oottamasathien and Crawford
Siam Oottamasathien and E. David Crawford
Arch Intern Med. 2003;163(6):665-666.
EXTRACT | FULL TEXT  

Rebuttal by Dr Hoffman
Richard M. Hoffman
Arch Intern Med. 2003;163(6):666.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Measuring plasma B-type natriuretic peptide in heart failure: Good to go in 2004?
Rodeheffer
J Am Coll Cardiol 2004;44:740-749.
ABSTRACT | FULL TEXT